PT - JOURNAL ARTICLE AU - Mellor, Jonathon AU - Tang, Maria L AU - Finch, Emilie AU - Christie, Rachel AU - Polhill, Oliver AU - Overton, Christopher E AU - Hoban, Ann AU - Douglas, Amy AU - Deeny, Sarah R AU - Ward, Thomas TI - An Application of Nowcasting Methods: Cases of Norovirus during the Winter 2023/2024 in England AID - 10.1101/2024.07.19.24310696 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.19.24310696 4099 - http://medrxiv.org/content/early/2024/07/19/2024.07.19.24310696.short 4100 - http://medrxiv.org/content/early/2024/07/19/2024.07.19.24310696.full AB - Background Norovirus is a leading cause of acute gastroenteritis, adding to strain on healthcare systems. Diagnostic test reporting of norovirus is often delayed, resulting in incomplete data for real-time surveillance.Methods To nowcast the real-time case burden of norovirus a generalised additive model, semi-mechanistic Bayesian joint process and delay model, and Bayesian structural time series model including syndromic surveillance data were developed. These models were evaluated over weekly nowcasts using a probabilistic scoring framework.Results Modelling current cases clearly outperforms a simple heuristic approach. Models that harnessed a time delay correction had higher skill, overall, relative to forecasting techniques. However, forecasting approaches were found to be more reliable in the event of temporally changeable reporting patterns. The incorporation of norovirus syndromic surveillance data was not shown to improve model skill in this nowcasting task, which may be indicative poor correlation between the indicator and norovirus incidence.Interpretation Analysis of surveillance data enhanced by nowcasting reporting delays improves understanding over simple model assumptions, which is important for real-time decision making. The structure of the modelling approach needs to be informed by the patterns of the reporting delay and can have large impacts on operational performance and insights produced.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UKHSA have an exemption under regulation 3 of section 251 of the National Health Service Act (2006) to allow identifiable patient information to be processed to diagnose, control, prevent, or recognise trends in, communicable diseases and other risks to public health.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesTraining data for the models explored in this manuscript is available at https://github.com/jonathonmellor/norovirus-nowcast. This data is aggregate with statistical noise added to preserve anonymity. This data enables each model to be fit and can be used for the future development of nowcasting models. Code for running all models is available at https://github.com/jonathonmellor/norovirus-nowcast. Individual-level data on the reporting delay used to inform initial exploration are not available due to patient identifiability. An application for data access can be make to the UK Health Security Agency. UKHSA operates a robust governance process for applying to access protected data that considers: - the benefits and risks of how the data will be used - compliance with policy, regulatory and ethical obligations - data minimisation - how the confidentiality, integrity, and availability will be maintained - retention, archival, and disposal requirements - best practice for protecting data, including the application of 'privacy by design and by default', emerging privacy conserving technologies and contractual controls Access to protected data is always strictly controlled using legally binding data sharing contracts. UKHSA welcomes data applications from organisations looking to use protected data for public health purposes. To request an application pack or discuss a request for UKHSA data you would like to submit, contact DataAccess{at}ukhsa.gov.uk. https://github.com/jonathonmellor/norovirus-nowcast